Inhibitory Principles from Magnolia officinalis on Tumor Necrosis $Factor-{\alpha}$ Production in Lipopolysaccharide-Activated RAW264.7 cells

  • Cho, Jae-Youl (R and D Center, Daewoong Pharmaceutical Co. Ltd., Department of Immunology, Windeyer Inst. of Med. Sci., Univ. Coll. London Medical School) ;
  • Park, Ji-Soo (R and D Center, Daewoong Pharmaceutical Co. Ltd.) ;
  • Chae, Sook-Hee (R and D Center, Daewoong Pharmaceutical Co. Ltd.) ;
  • Lee, June-Goo (R and D Center, Daewoong Pharmaceutical Co. Ltd.) ;
  • Yoo, Eun-Sook (R and D Center, Daewoong Pharmaceutical Co. Ltd.) ;
  • Baik, Kyong-Up (R and D Center, Daewoong Pharmaceutical Co. Ltd.) ;
  • Lee, Jong-Soo (R and D Center, Daewoong Pharmaceutical Co. Ltd.) ;
  • Park, Myung-Hwan (R and D Center, Daewoong Pharmaceutical Co. Ltd.)
  • 발행 : 1999.06.01

초록

In the course of a search for tumor necrosis factor $(TNF)-{\alpha}$ inhibitory compounds from medicinal plants, we identified neolignans, honokiol and magnolol, from the alcoholic extract of Magnolia offcinalis as active inhibitory principles. These compounds dose-dependently inhibited $TNF-{\alpha}$ production without displaying cytotoxicity and their inhibitory activities measured by $IC_{50}$ values were 53.7 and $61.4\;{\mu}M$, respectively.

키워드